XYLO Stock Price, Chart, Stats & News

XYLO chart
Fundamentals
Gross margin | 23.91% |
Operating margin | 0.40% |
Pretax margin | -3.15% |
Net margin | 20.27% |
Effective tax rate | 63.86% |
ROA | 5.70% |
ROE | 11.90% |
D/E | 0.38x |
Interest coverage ratio | – |
XYLO valuation
P/E | – |
P/S | 0.36x |
P/B | 0.22x |
P/CF | -2.48x |
P/FCF | -2.38x |
P/OCF | -2.48x |
PEG | 0.04x |
EV multiple | -1.49x |
About
Operating from its Tel Aviv-Yafo, Israel headquarters since its establishment in 1999, Xylo Technologies Ltd. is a technology company with a broad international presence, serving markets in the United States, Europe, Asia, and Israel. The company's diverse operations are categorized into Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Other segments. In the medical field, Xylo Technologies develops and supplies devices such as the Medigus Ultrasonic Surgical Endostapler, an endoscopy system specifically designed for treating gastroesophageal reflux disease, alongside biological gels engineered to defend against biological hazards and minimize the entry of allergens and viruses through the upper airways and eyes.
Similar securities
Based on sector and market capitalization











